NDC Active Ingredient Crizotinib
Active Ingredient Information
What is Crizotinib?
A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER.
What is the usage for Crizotinib?
Crizotinib is used to treat certain types of lung cancer. Crizotinib works by slowing or stopping the growth of lung cancer cells. It belongs to a class of drugs known as kinase inhibitors.
How many products in the NDC database contain Crizotinib?
The NDC database has 5 products with the active ingredient Crizotinib. The following table lists all the products that have this active ingredient.
NDC Products with Crizotinib
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0069-8140 | Proprietary Name: Xalkori | Crizotinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
| 0069-8141 | Proprietary Name: Xalkori | Crizotinib | Capsule | Oral | Pfizer Laboratories Div Pfizer Inc | ACTIVE | |
| 53869-2230 | Proprietary Name: | Crizotinib | Capsule | Pfizer Manufacturing Deutschland Gmbh (betriebsst�tte Freiburg) | ACTIVE | ||
| 53869-2231 | Proprietary Name: | Crizotinib | Capsule | Pfizer Manufacturing Deutschland Gmbh (betriebsst�tte Freiburg) | ACTIVE | ||
| 68724-1020 | Proprietary Name: | Crizotinib | Powder | Pfizer Asia Manufacturing Pte Ltd | ACTIVE |